Teva Pharmaceutical Industries Limited (TEVA) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "TEVA"
      ],
      "issuer_cik": "0000818686",
      "owner_cik": "0002112339",
      "accession_number": "0001193125-26-398105",
      "form_type": "4",
      "filing_date": "2026-09-22",
      "period_of_report": "2026-09-18",
      "issuer_name": "TEVA PHARMACEUTICAL INDUSTRIES LTD",
      "issuer_trading_symbol": "TEVA",
      "owner_name": "Savage Brian",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Interim Chief Legal Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Ordinary Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-09-18",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 2525,
      "transaction_price_per_share": 39.145,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 8814,
      "transaction_value": 98841.12500000001,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.14 to $39.155, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."
        }
      ]
    },
    {
      "tickers": [
        "TEVA"
      ],
      "issuer_cik": "0000818686",
      "owner_cik": "0001258394",
      "accession_number": "0001193125-26-397959",
      "form_type": "4",
      "filing_date": "2026-09-22",
      "period_of_report": "2026-09-19",
      "issuer_name": "TEVA PHARMACEUTICAL INDUSTRIES LTD",
      "issuer_trading_symbol": "TEVA",
      "owner_name": "MIGNONE ROBERTO",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Ordinary Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-09-18",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 367600,
      "transaction_price_per_share": 39.0555,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 0,
      "transaction_value": 14356801.8,
      "direct_or_indirect": "I",
      "nature_of_ownership": "[see footnote]",
      "footnotes": [
        {
          "id": "F1",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.68 to $39.38, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."
        },
        {
          "id": "F2",
          "description": "The 367,600 Ordinary Shares disclosed in Table I of this Form 4 were held of record by Swiftcurrent Master Fund Ltd. (the \"Fund\"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone was deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaimed beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone was the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.